|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2006-11-27
|
|
pubmed:abstractText |
The authors evaluated the long-term efficacy and side effects in patients with nonmetastatic, unilateral, inflammatory breast cancer (IBC) who received homogeneous treatment with intensive induction chemotherapy followed by a maintenance regimen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2006 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2535-44
|
|
pubmed:meshHeading |
pubmed-meshheading:17054108-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17054108-Breast Neoplasms,
pubmed-meshheading:17054108-Chemotherapy, Adjuvant,
pubmed-meshheading:17054108-Cyclophosphamide,
pubmed-meshheading:17054108-Disease-Free Survival,
pubmed-meshheading:17054108-Dose-Response Relationship, Drug,
pubmed-meshheading:17054108-Epirubicin,
pubmed-meshheading:17054108-Female,
pubmed-meshheading:17054108-Fluorouracil,
pubmed-meshheading:17054108-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:17054108-Humans,
pubmed-meshheading:17054108-Inflammation,
pubmed-meshheading:17054108-Placebos,
pubmed-meshheading:17054108-Recombinant Proteins,
pubmed-meshheading:17054108-Remission Induction,
pubmed-meshheading:17054108-Survival Rate
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial.
|
|
pubmed:affiliation |
Department of Medical Oncology, Henri Becquerel Center, Rouen, France. cveyret@rouen.fnclcc.fr
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
